1-10 of 10
proprietary drug
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Variables Associated with Patient-Reported Symptoms in Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors

Lu Yu, MD, Qian Jiang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1605.
https://doi.org/10.1182/blood.V130.Suppl_1.1605.1605
Published: 2017
Journal Articles

Out-of-Pocket (OOP) Costs Associated with Tyrosine Kinase Inhibitors (TKIs) Used for the Treatment of US Patients Diagnosed with Chronic Myeloid Leukemia (CML): A US Retrospective Claims Analysis

Ruth Kim, Deepa Malhotra, Timothy Bell, Fiona An, MD, Jack Mardekian
Journal: Blood
Blood (2017) 130 (Supplement 1): 2123.
https://doi.org/10.1182/blood.V130.Suppl_1.2123.2123
Published: 2017
Journal Articles

Age and Cost Are Associated with Patient Preference for Stopping Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Qian Jiang, Zheng-Chen Liu, Song-Xin Zhang, Jing Li, Robert Peter Gale, MD PhD DSc
Journal: Blood
Blood (2015) 126 (23): 1585.
https://doi.org/10.1182/blood.V126.23.1585.1585
Published: 2015
Journal Articles

Use of Thrombin Generation Assay As Tool for the Evaluation of the Antithrombotic Samenesse of Enoxaparine Copies

Grigorios T. Gerotziafas, Dr, Patrick Van Dreden, PhD, Aurélie Rousseau, Amir Khaterchi, Jeanine M. Walenga, PhD, Jawed Fareed, PhD, Ismail Elalamy, MD
Journal: Blood
Blood (2014) 124 (21): 5092.
https://doi.org/10.1182/blood.V124.21.5092.5092
Published: 2014
Journal Articles

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis.

Amy J. Davidoff, M.S., Ph.D., Franklin Hendrick, B.S., Bruce C. Stuart, PhD, Amer M. Zeidan, MD, Rahul Shenolikar, PhD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 3176.
https://doi.org/10.1182/blood.V120.21.3176.3176
Published: 2012
Journal Articles

Assessment of Clinical Safety and Estimate of Survival in Iraqi Patients with Chronic Myeloid Leukemia Switched From Glivec (β-Crystalline Form of Imatinib Mesylate) to an α-Crystalline Copy of Imatinib Mesylate

Marc Botteman, MSc, MA, Matthew Magestro, Alaa Fadhil Alwan, MD, Paul W Manley, PhD, Oleg Zernovak, MD, Richard C. Woodman
Journal: Blood
Blood (2012) 120 (21): 4439.
https://doi.org/10.1182/blood.V120.21.4439.4439
Published: 2012
Journal Articles

Cost-Effectiveness of Targeted Cancer Therapies for Hematological Malignancies.

Ozlem Topaloglu, Ph.D, MPH, Chuck Stevens, JD, MBA, Saurabh Aggarwal, PhD
Journal: Blood
Blood (2009) 114 (22): 4547.
https://doi.org/10.1182/blood.V114.22.4547.4547
Published: 2009
Journal Articles

Targeting the JAK2 Kinase in Hematological Malignancies.

Colin E. Olsen, MS, Eric S. Gourley, BS, Xiao-Hui Lui, PhD, Jeff Walker, BS, Cory L. Grand, PhD, Steven L. Warner, PhD, Hariprasad Vankayalapati, PhD, David J. Bearss, PhD
Journal: Blood
Blood (2007) 110 (11): 3560.
https://doi.org/10.1182/blood.V110.11.3560.3560
Published: 2007
Journal Articles

Generic and Branded Low Molecular Weight Heparins Can Be Differentiated Based on Biologic and Pharmacologic Assays.

Walter P. Jeske, PhD, Paul Ackerman, B.S., Amanda Drenth, B.S., Jeanine M. Walenga, Ph.D, Mamdouh Bakhos, M.D.
Journal: Blood
Blood (2007) 110 (11): 1885.
https://doi.org/10.1182/blood.V110.11.1885.1885
Published: 2007
Journal Articles

Lenalidomide (CC5013, Revlimid®) Alters a T Cell Homeostatic Check-Point in Patients with Myelodysplastic Syndrome (MDS).

JianXiang Zou, MD, Edna Ku, MD, PhD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Alan F. List, MD, P.K. Epling-Burnette, PhD
Journal: Blood
Blood (2006) 108 (11): 851.
https://doi.org/10.1182/blood.V108.11.851.851
Published: 2006